BioRestorative Therapies, Inc. Common Stock (NV) Profile
About
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's core programs consist of Disc/Spine Program and Metabolic Program. Disc/Spine Program consists of cell therapy candidate, brtxDISC(TM) is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow. Metabolic Program consists of ThermoStem(R), developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. BioRestorative Therapies, Inc. is based in Melville, New York.
Info & Links
CEO
Lance Alstodt
Headquarters
40 MARCUS DRIVE, SUITE 1 MELVILLE, NY 11747, UNITED STATES
BioRestorative Therapies, Inc. Common Stock (NV) Statistics
Valuation Measures
Market Capitalization2
11.94M
Enterprise Value
10.50M
Enterprise Value/EBITDA(ttm)
-0.88
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
35.98
Price to Book(mrq)
1.36
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
94.30%
Operating Margin(ttm)
-3055.70%
Profit Margin(ttm)
-3779.85%
Return on Equity(ttm)
-98.49%
Return on Invested Capital(ttm)
-82.73%
Return on Assets(ttm)
-75.23%
Income Statement
Revenue(ttm)
377.00K
Revenue Per Share(ttm)
0.05
Gross Profit(ttm)
352.30K
EBITDA(ttm)3
-11.90M
Net Income Available to Common(ttm)
-13.65M
Diluted EPS(ttm)
-1.53
Share Statistics
Beta (5Y Monthly)
62.62
52-Week Change
31.68%
S&P 500 52-Week Change
-2.50%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
6.92M
Dividend Yield
0.00%
Float4
5.16M
% Held by Insiders
25.50%
% Held by Institutions
69.38%
Balance Sheet
Total Cash(mrq)
13.09M
Total Cash Per Share(mrq)
1.89
Total Debt(mrq)
42.40K
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
2.97%
Quick Ratio(mrq)
2.95%
Book Value Per Share(mrq)
1.23
Cash Flow
Operating Cash Flow Per Share(ytd)
-1.06
Free Cash Flow(ytd)
-8.34M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.